Tiagabine.txt CLINICAL USE Anti-epileptic agent DOSE IN NORMAL RENAL FUNCTION 15–45 mg daily in 3 divided doses if dose >30 mg PHARMACOKINETICS Molecular weight                           : 412 %Protein binding                           : 96 %Excreted unchanged in urine     : <2 Volume of distribution (L/kg)       : 1 half-life – normal/ESRD (hrs)      : 7–9 (2–3 in patients on enzyme inducing drugs) DOSE IN RENAL IMPAIRMENT GFR (mL/MIN) 20 to 50     : Dose as in normal renal function 10 to 20     : Dose as in normal renal function <10           : Dose as in normal renal function DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES CAPD                : Unknown dialysability. Dose as in normal renal function HD                     : Not dialysed. Dose as in normal renal function HDF/high flux   : Unknown dialysability. Dose as in normal renal function CAV/VVHD      : Unknown dialysability. Dose as in normal renal function IMPORTANT DRUG INTERACTIONS Potentially hazardous interactions with other drugs Antidepressants: antagonism of anticonvulsant effect (convulsive threshold lowered) Anti-epileptics: concentration reduced by phenytoin, carbamazepine, phenobarbital and primidone Antimalarials: mefloquine antagonises anticonvulsant effect; chloroquine and hydroxychloroquine occasionally reduce convulsive threshold ADMINISTRATION Reconstition – Route Oral Rate of Administration – Comments – OTHER INFORMATION Although there is no evidence of withdrawal seizures, it is recommended to taper off treatment over a period of 2–3 weeks . Tags: post-by-auto-php Continue Reading Previous Previous post: Temocillin.txtNext Next post: Trandolapril.txt Related News sotalol hydrochloride.txt tazocin.txt